Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Law & Regulation
November 16, 2020 05:10 PM

Trump's executive order on drug rebate rule may not be binding

Rachel Cohrs
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Modern Healthcare Illustration / Getty Images

    The Trump administration's executive order placing restrictions on rulemaking requiring middlemen to pass drug rebates directly to patients may not be legally binding.

    HHS on Friday submitted a final rule to the White House budget office that would prohibit pharmacy benefit managers from retaining rebates paid by drugmakers. The president in July signed an executive order stating that the HHS secretary must publicly certify that any such policy will not increase insurance premiums, federal spending or Medicare beneficiaries' out-of-pocket costs. However, regulatory experts say the agency could likely work around the order.

    Drugmakers like the policy as it insulates patients from the sticker prices of some expensive drugs, while pharmacy benefit managers and insurers oppose it.

    If the administration releases a final rule, it could go into effect in 60 days. That means the rule would need to be released this week to be effective before Inauguration Day, when any policies not finalized could be stalled by the new Biden administration.

    Even the most favorable cost analyses of the proposed rebate rule estimated that it would increase Medicare beneficiaries' premiums in all scenarios. The finding reflects the rule's design to take money insurers currently use to keep premiums low across all beneficiaries and use it to lower out-of-pocket costs for a smaller subset of individuals taking drugs that have high rebates.

    "Eliminating rebates without raising premiums presents the ultimate public policy paradox," said Thorn Run Partners Senior Vice President Shea McCarthy.

    The administration could potentially commission a new analysis if it wanted to comply with the order or make changes to the policy. But the secretary isn't legally bound to any particular analysis when certifying the rule's financial impacts. HHS Secretary Alex Azar has argued that plans would keep premiums low because they compete on the basis of premiums in the Medicare Part D program.

    "I think there is a scenario where the secretary could make an assumption that premiums will not increase," said Kelly Cleary, a partner at Akin Gump Strauss Hauer & Feld and a former deputy general counsel at HHS under the Trump administration.

    The executive order isn't binding for the administration and carries no legal significance, Cleary said.

    The rule is currently listed on the White House budget office's website as "economically significant," which means that it is either likely to have an annual effect on the economy of at least $100 million or adversely affect in a material way the economy or a sector of the economy. It doesn't necessarily indicate federal costs.

    "This economic impact does not have to pertain to government costs, Medicare premiums, or out of pocket costs," said Dan Bosch, the director of regulatory policy at the American Action Forum.

    HHS declined to comment on the rulemaking process. The agency previously said it had withdrawn the rule after policy conflict within the administration, but it was apparently not technically withdrawn from all formal rulemaking channels.

    The policy has powerful opponents in the Trump administration, but also an important proponent: White House Chief of Staff Mark Meadows. Meadows as a congressman circulated a letter to colleagues urging Azar to finalize the proposed rule.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    chevron-main-0724
    What policies could be affected by the Chevron ruling
    legal gavel 24
    SCAN wins Medicare Advantage star ratings lawsuit against CMS
    Most Popular
    1
    UnitedHealth under criminal investigation for Medicare fraud: WSJ
    2
    States, providers face brunt of GOP Medicaid cuts plan
    3
    UnitedHealth Group to cut Medicare drug plan commissions
    4
    Federal dementia pilot has rocky rollout for some providers
    5
    'Legendary' Hemsley takes over at UnitedHealth amid rough seas
    Sponsored Content
    Daily Dose Newsletter: Sign up to receive a late afternoon weekday roundup of that day’s breaking news and developments in healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content